In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Clinical case Results

EHRA 2023, Barcelona & online from 16 to 18 April

Clinical case results are now available

The EHRA Scientific Programme Committee would like to thank all the contributors who have chosen EHRA 2023 to submit their clinical case.  

An email has been sent to each submitter.

Confirm and upload your presentation

Confirmation of your presentation should be done as soon as possible.

STEP 1 - The submitter must sign in to her/his My ESC account with the email and password used at the time of submission to consult the abstract presentation day, time and format. 

STEP 2 - The presenter must register to the congress - you benefit from the early fee until 21 February 2023

STEP 3 - The presenter can start preparing her/his presentation to upload it by the set deadline, as indicated in the agreement form. Review the Presenter Guidelines.

Key dates

Mid-January 2023 - Abstract results announcement. An email will also be sent to each submitter.

21 February 2023 - Early fee registration deadline.

Early February 2022 - Upload opening.

16 March 2023 - Deadline to upload your presentation and register for the congress.

Presentation formats

All presentations are planned to take place in-person in Barcelona.
Selected clinical cases have been assigned to different sessions.

Each session is built to give the maximum visibility to the research and the opportunity for exchange and interactions with peers and key opinion leaders.

Clinical case session

You will present your clinical case orally in a dedicated Clinical Case session which will allow you to interact with the audience and expert discussants.

For more information on the presentation format, please refer to the presenter guidelines.